AMP-activated protein kinase: The guerdian of cardiac energy status

Journal of Clinical Investigation

Volumn 114, Issue 4, 2004, Pages 465-468

  Hardie, D Grahame ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; DRUG DERIVATIVE; MULTIENZYME COMPLEX; PROTEIN SERINE THREONINE KINASE; RIBONUCLEOSIDE; TRANSACTIVATOR PROTEIN;

APOPTOSIS; CELL PROTECTION; ENERGY CONSUMPTION; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE REPERFUSION; HUMAN; ISCHEMIA; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; ANIMAL; BIOLOGICAL MODEL; ENERGY METABOLISM; GENETICS; HEART MUSCLE ISCHEMIA; METABOLISM; NECROSIS; NOTE; PATHOLOGY; REPERFUSION INJURY;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; APOPTOSIS; ENERGY METABOLISM; ENZYME ACTIVATION; HUMANS; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEOSIDES; TRANS-ACTIVATORS;

EID: 4344682934     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200422683     Document Type: Review

References (19)

1. Hardie, D.G., Scott, J.W., Pan, D.A., and Hudson, E.R. 2003. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546:113-120.
2. Russell, R.R., Bergeron, R., Shulman, G.I., and Young, L.H. 1999. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol. 277:H643-H649.
3. Luiken, J.J., et al. 2003. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes. 52:1627-1634.
4. Kudo, N., Barr, A.J., Barr, R.L., Desai, S., and Lopaschuk, G.D. 1995. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 270:17513-17520.
5. Moore, P., Weekes, J., and Hardie, D.G. 1991. AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase. A sensitive mechanism to protect the cell against ATP depletion. Eur. J. Biochem. 199:691-697.
6. Witters, L.A., Nordlund, A.C., and Marshall, L. 1991. Regulation of intracellular acetyl-CoA carboxylase by ATP depletors mimics the action of the 5′-AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 181:1486-1492.
7. Marsin, A.S., et al. 2000. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10:1247-1255.
8. Russell, R.R., III, et al. 2004. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin. Invest. 114:495-503. doi:10.1172/ JCI200419297.
9. Mu, J., Brozinick, J.T., Valladares, O., Bucan, M., and Birnbaum, M.J. 2001. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell. 7:1085-1094.
10. Hudson, E.R., et al. 2003. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol. 13:861-866.
11. Polekhina, G., et al. 2003. AMPK b-Subunit targets metabolic stress-sensing to glycogen. Curr. Biol. 13:867-871.
12. Scott, J.W., et al. 2004. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 113:274-284. doi:10.1172/JCI200419874.
13. Xing, Y., et al. 2003. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J. Biol. Chem. 278:28372-28377.
14. Mangano, D.T. 1997. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. JAMA. 277:325-332.
15. Gadalla, A.E., et al. 2004. Distinct mechanisms underlie the activation of rat brain AMP-activated protein kinase and the inhibition of excitatory synaptic transmission by AICA riboside (Acadesine) in area CA1 of rat hippocampus. J. Neurochem. 88:1272-1282.
16. Corton, J.M., Gillespie, J.G., Hawley, S.A., and Hardie, D.G. 1995. 5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 229:558-565.
17. Javaux, F., Vincent, M.F., Wagner, D.R., and van den Berghe, G. 1995. Cell-type specificity of inhibition of glycolysis by 5-amino-4- imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells. Biochem. J. 305:913-919.
18. Andersson, U., et al. 2004. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279:12005-12008.
19. Minokoshi, Y., et al. 2004. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 428:569-574.